Hepatitis in an infant treated with octreotide for congenital hyperinsulinism
Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed an...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
De Gruyter ; 2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
3 |
|---|
| Reproduktion: |
Walter de Gruyter Online Zeitschriften |
|---|---|
| Übergeordnetes Werk: |
Enthalten in: The journal of pediatric endocrinology and metabolism - Berlin [u.a.] : de Gruyter, 1985, 26(2013), 1-2 vom: 17. Jan., Seite 183-185 |
| Übergeordnetes Werk: |
volume:26 ; year:2013 ; number:1-2 ; day:17 ; month:01 ; pages:183-185 ; extent:3 |
| Links: |
|---|
| DOI / URN: |
10.1515/jpem-2012-0372 |
|---|
| Katalog-ID: |
NLEJ247122483 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ247122483 | ||
| 003 | DE-627 | ||
| 005 | 20230506114702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220814s2013 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1515/jpem-2012-0372 |2 doi | |
| 028 | 5 | 2 | |a artikel_Grundlieferung.pp |
| 035 | |a (DE-627)NLEJ247122483 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 245 | 1 | 0 | |a Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| 264 | 1 | |b De Gruyter |c 2013 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. | ||
| 533 | |f Walter de Gruyter Online Zeitschriften | ||
| 650 | 4 | |a congenital hyperinsulinism | |
| 700 | 1 | |a Koren, Ilana |4 oth | |
| 700 | 1 | |a Riskin, Arieh |4 oth | |
| 700 | 1 | |a Barthlen, Winfried |4 oth | |
| 700 | 1 | |a Gillis, David |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of pediatric endocrinology and metabolism |d Berlin [u.a.] : de Gruyter, 1985 |g 26(2013), 1-2 vom: 17. Jan., Seite 183-185 |w (DE-627)NLEJ248236202 |w (DE-600)2583847-7 |x 2191-0251 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2013 |g number:1-2 |g day:17 |g month:01 |g pages:183-185 |g extent:3 |
| 856 | 4 | 0 | |u https://doi.org/10.1515/jpem-2012-0372 |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DGR | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2013 |e 1-2 |b 17 |c 01 |h 183-185 |g 3 | ||
| matchkey_str |
article:21910251:2013----::eaiiiaifntetdihcroieocnei |
|---|---|
| hierarchy_sort_str |
2013 |
| publishDate |
2013 |
| allfields |
10.1515/jpem-2012-0372 doi artikel_Grundlieferung.pp (DE-627)NLEJ247122483 DE-627 ger DE-627 rakwb Hepatitis in an infant treated with octreotide for congenital hyperinsulinism De Gruyter 2013 3 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. Walter de Gruyter Online Zeitschriften congenital hyperinsulinism Koren, Ilana oth Riskin, Arieh oth Barthlen, Winfried oth Gillis, David oth Enthalten in The journal of pediatric endocrinology and metabolism Berlin [u.a.] : de Gruyter, 1985 26(2013), 1-2 vom: 17. Jan., Seite 183-185 (DE-627)NLEJ248236202 (DE-600)2583847-7 2191-0251 nnns volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 https://doi.org/10.1515/jpem-2012-0372 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 26 2013 1-2 17 01 183-185 3 |
| spelling |
10.1515/jpem-2012-0372 doi artikel_Grundlieferung.pp (DE-627)NLEJ247122483 DE-627 ger DE-627 rakwb Hepatitis in an infant treated with octreotide for congenital hyperinsulinism De Gruyter 2013 3 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. Walter de Gruyter Online Zeitschriften congenital hyperinsulinism Koren, Ilana oth Riskin, Arieh oth Barthlen, Winfried oth Gillis, David oth Enthalten in The journal of pediatric endocrinology and metabolism Berlin [u.a.] : de Gruyter, 1985 26(2013), 1-2 vom: 17. Jan., Seite 183-185 (DE-627)NLEJ248236202 (DE-600)2583847-7 2191-0251 nnns volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 https://doi.org/10.1515/jpem-2012-0372 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 26 2013 1-2 17 01 183-185 3 |
| allfields_unstemmed |
10.1515/jpem-2012-0372 doi artikel_Grundlieferung.pp (DE-627)NLEJ247122483 DE-627 ger DE-627 rakwb Hepatitis in an infant treated with octreotide for congenital hyperinsulinism De Gruyter 2013 3 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. Walter de Gruyter Online Zeitschriften congenital hyperinsulinism Koren, Ilana oth Riskin, Arieh oth Barthlen, Winfried oth Gillis, David oth Enthalten in The journal of pediatric endocrinology and metabolism Berlin [u.a.] : de Gruyter, 1985 26(2013), 1-2 vom: 17. Jan., Seite 183-185 (DE-627)NLEJ248236202 (DE-600)2583847-7 2191-0251 nnns volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 https://doi.org/10.1515/jpem-2012-0372 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 26 2013 1-2 17 01 183-185 3 |
| allfieldsGer |
10.1515/jpem-2012-0372 doi artikel_Grundlieferung.pp (DE-627)NLEJ247122483 DE-627 ger DE-627 rakwb Hepatitis in an infant treated with octreotide for congenital hyperinsulinism De Gruyter 2013 3 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. Walter de Gruyter Online Zeitschriften congenital hyperinsulinism Koren, Ilana oth Riskin, Arieh oth Barthlen, Winfried oth Gillis, David oth Enthalten in The journal of pediatric endocrinology and metabolism Berlin [u.a.] : de Gruyter, 1985 26(2013), 1-2 vom: 17. Jan., Seite 183-185 (DE-627)NLEJ248236202 (DE-600)2583847-7 2191-0251 nnns volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 https://doi.org/10.1515/jpem-2012-0372 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 26 2013 1-2 17 01 183-185 3 |
| allfieldsSound |
10.1515/jpem-2012-0372 doi artikel_Grundlieferung.pp (DE-627)NLEJ247122483 DE-627 ger DE-627 rakwb Hepatitis in an infant treated with octreotide for congenital hyperinsulinism De Gruyter 2013 3 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. Walter de Gruyter Online Zeitschriften congenital hyperinsulinism Koren, Ilana oth Riskin, Arieh oth Barthlen, Winfried oth Gillis, David oth Enthalten in The journal of pediatric endocrinology and metabolism Berlin [u.a.] : de Gruyter, 1985 26(2013), 1-2 vom: 17. Jan., Seite 183-185 (DE-627)NLEJ248236202 (DE-600)2583847-7 2191-0251 nnns volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 https://doi.org/10.1515/jpem-2012-0372 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 26 2013 1-2 17 01 183-185 3 |
| source |
Enthalten in The journal of pediatric endocrinology and metabolism 26(2013), 1-2 vom: 17. Jan., Seite 183-185 volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 |
| sourceStr |
Enthalten in The journal of pediatric endocrinology and metabolism 26(2013), 1-2 vom: 17. Jan., Seite 183-185 volume:26 year:2013 number:1-2 day:17 month:01 pages:183-185 extent:3 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
congenital hyperinsulinism |
| isfreeaccess_bool |
false |
| container_title |
The journal of pediatric endocrinology and metabolism |
| authorswithroles_txt_mv |
Koren, Ilana @@oth@@ Riskin, Arieh @@oth@@ Barthlen, Winfried @@oth@@ Gillis, David @@oth@@ |
| publishDateDaySort_date |
2013-01-17T00:00:00Z |
| hierarchy_top_id |
NLEJ248236202 |
| id |
NLEJ247122483 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ247122483</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506114702.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2013 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/jpem-2012-0372</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ247122483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis in an infant treated with octreotide for congenital hyperinsulinism</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">De Gruyter</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">congenital hyperinsulinism</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koren, Ilana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riskin, Arieh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barthlen, Winfried</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gillis, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">The journal of pediatric endocrinology and metabolism</subfield><subfield code="d">Berlin [u.a.] : de Gruyter, 1985</subfield><subfield code="g">26(2013), 1-2 vom: 17. Jan., Seite 183-185</subfield><subfield code="w">(DE-627)NLEJ248236202</subfield><subfield code="w">(DE-600)2583847-7</subfield><subfield code="x">2191-0251</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1-2</subfield><subfield code="g">day:17</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:183-185</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/jpem-2012-0372</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2013</subfield><subfield code="e">1-2</subfield><subfield code="b">17</subfield><subfield code="c">01</subfield><subfield code="h">183-185</subfield><subfield code="g">3</subfield></datafield></record></collection>
|
| series2 |
Walter de Gruyter Online Zeitschriften |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ248236202 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2191-0251 |
| topic_title |
Hepatitis in an infant treated with octreotide for congenital hyperinsulinism congenital hyperinsulinism |
| publisher |
De Gruyter |
| publisherStr |
De Gruyter |
| topic |
misc congenital hyperinsulinism |
| spellingShingle |
misc congenital hyperinsulinism Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| topic_unstemmed |
misc congenital hyperinsulinism |
| topic_browse |
misc congenital hyperinsulinism |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| author2_variant |
i k ik a r ar w b wb d g dg |
| hierarchy_parent_title |
The journal of pediatric endocrinology and metabolism |
| hierarchy_parent_id |
NLEJ248236202 |
| hierarchy_top_title |
The journal of pediatric endocrinology and metabolism |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ248236202 (DE-600)2583847-7 |
| title |
Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| ctrlnum |
(DE-627)NLEJ247122483 |
| title_full |
Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| journal |
The journal of pediatric endocrinology and metabolism |
| journalStr |
The journal of pediatric endocrinology and metabolism |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
txt |
| container_start_page |
183 |
| container_volume |
26 |
| physical |
3 |
| format_se |
Elektronische Aufsätze |
| doi_str_mv |
10.1515/jpem-2012-0372 |
| title_sort |
hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| title_auth |
Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| abstract |
Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. |
| abstractGer |
Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. |
| abstract_unstemmed |
Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE |
| container_issue |
1-2 |
| title_short |
Hepatitis in an infant treated with octreotide for congenital hyperinsulinism |
| url |
https://doi.org/10.1515/jpem-2012-0372 |
| remote_bool |
true |
| author2 |
Koren, Ilana Riskin, Arieh Barthlen, Winfried Gillis, David |
| author2Str |
Koren, Ilana Riskin, Arieh Barthlen, Winfried Gillis, David |
| ppnlink |
NLEJ248236202 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1515/jpem-2012-0372 |
| up_date |
2024-07-06T10:00:12.824Z |
| _version_ |
1803823363209035776 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ247122483</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506114702.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2013 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/jpem-2012-0372</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ247122483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis in an infant treated with octreotide for congenital hyperinsulinism</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">De Gruyter</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">congenital hyperinsulinism</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koren, Ilana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riskin, Arieh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barthlen, Winfried</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gillis, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">The journal of pediatric endocrinology and metabolism</subfield><subfield code="d">Berlin [u.a.] : de Gruyter, 1985</subfield><subfield code="g">26(2013), 1-2 vom: 17. Jan., Seite 183-185</subfield><subfield code="w">(DE-627)NLEJ248236202</subfield><subfield code="w">(DE-600)2583847-7</subfield><subfield code="x">2191-0251</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1-2</subfield><subfield code="g">day:17</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:183-185</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/jpem-2012-0372</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2013</subfield><subfield code="e">1-2</subfield><subfield code="b">17</subfield><subfield code="c">01</subfield><subfield code="h">183-185</subfield><subfield code="g">3</subfield></datafield></record></collection>
|
| score |
7.400014 |